Profiles

Keywords
Last Name
Institution

Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.

Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Peters SU, Jones NE, Youakim JM. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemp Clin Trials. 2022 03; 114:106704.

View in: PubMed

collapse authors with profiles